According to a new market report published by Lucintel, the future of the prosthetic heart valve market looks promising with opportunities in the cardiovascular applications. The prosthetic heart valve/artificial heart valve market is expected to grow with a CAGR of 13% from 2019 to 2024. The major growth drivers for this market are increasing geriatric population, growing frequency of structural heart diseases, and technical advancement, and rising awareness on heart valve diseases.
In this market, transcatheter heart valves and tissue heart valves are the major valves used in a cardiac surgery to replace an abnormal heart valve with an artificial heart valve. Transcatheter heart valve is expected to witness the largest segment due to ease of implantation and increasing prevalence of aortic stenosis.
North America will remain the largest region over the forecast period due to rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valve market.
Medtronic, Edwards Lifesciences, Boston Scientific, Livanova, St. Jude Medical, Symetis, Jenavalve Technology, Cryolife, TTK Healthcare, Colibri Heart Valve, Lepu Medical Technology, and Braile Biomédica are among the major manufacturers of prosthetic heart valve/artificial heart valve.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the prosthetic heart valve market by valve type and region. Lucintel has prepared a comprehensive research report titled "Prosthetic Heart Valve Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the prosthetic heart valve/ artificial heart valve market by type of valve and region as follows:
By Valve Type [$M shipment analysis for 2013 – 2024]:
• Transcatheter Heart Valves
• Tissue Heart Valves
By Region [$M shipment analysis for 2013 – 2024]:
• North America
• United States
• Canada
• Mexico
• Europe
• UK
• Germany
• Italy
• Asia Pacific
• China
• Japan
• India
• Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this ……. [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the prosthetic heart valve/ artificial heart valve market by type of valve (transcatheter heart valves and tissue heart valves), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the prosthetic heart valve/ artificial heart valve market?
Q.5. What are the business risks and threats to the prosthetic heart valve/ artificial heart valve market?
Q.6. What are emerging trends in this prosthetic heart valve/ artificial heart valve market and the reasons behind them?
Q.7. What are some changing demands of customers in the prosthetic heart valve/ artificial heart valve market?
Q.8. What are the new developments in the prosthetic heart valve/ artificial heart valve market? Which companies are leading these developments?
Q.9. Who are the major players in this prosthetic heart valve/ artificial heart valve market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this prosthetic heart valve/ artificial heart valve area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in prosthetic heart valve/ artificial heart valve market?